Literature DB >> 1498494

Effect of prostacycline analogue OP-41483 and perfusate on liver preservation by simple hypothermia in rats.

S Noshima1.   

Abstract

Changes in rat livers preserved by simple cooling immersion in modified Sacks' solution, Ross' solution and Ross' solution with OP-41483, a PGI2 analogue, were compared after 12, 24, 36, and 48 hours. The viability of the preserved livers was assessed by measuring the tissue ATP concentrations and quantifying morphologic changes in the mitochondria observed by transmission electron microscopy using a 4-point scale, the mitochondrial score. A general trend towards progressive mitochondrial degeneration was observed in all groups. After 12 hrs of preservation, there was no significant difference between the groups. From 24 to 48 hours, the mitochondrial scores for livers preserved with OP-41483 were significantly higher than in the two other groups. No difference among the groups in tissue ATP concentration was observed at any time. Thus, OP-41483 was considered to retard mitochondrial degeneration in liver preservation by simple hypothermic immersion and does so by a mechanism not directly related to intracellular energy stores. The possibility that OP-41483 acts by stabilizing the lysosomal membrane is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498494     DOI: 10.1007/bf00311340

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Studies by electron microscope on various forms of induced cardiac arrest in dog and rabbit.

Authors:  B HOELSCHER; O H JUST; H J MERKER
Journal:  Surgery       Date:  1961-04       Impact factor: 3.982

2.  A comparative study of aortic occlusion alone and of potassium citrate arrest during cardiopulmonary bypass.

Authors:  D D NUNN; C A BELISLE; W H LEE; E F PARKER
Journal:  Surgery       Date:  1959-05       Impact factor: 3.982

3.  72-hr canine kidney preservation without continuous perfusion.

Authors:  H Ross; V C Marshall; M L Escott
Journal:  Transplantation       Date:  1976-06       Impact factor: 4.939

4.  Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.

Authors:  A M Lefer; M L Ogletree; J B Smith; M J Silver; K C Nicolaou; W E Barnette; G P Gasic
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

5.  Hypothermic preservation of the rat liver assessed by orthotopic transplantation. A comparison of flush solutions.

Authors:  T Tamaki; N Kamada; D E Pegg
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939

6.  Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin.

Authors:  M Monden; J G Fortner
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

7.  Hypothermic preservation of the rat liver assessed by orthotopic transplantation. II. Evaluation of citrate solutions.

Authors:  T Tamaki; N Kamada; D G Wight; D E Pegg
Journal:  Transplantation       Date:  1987-03       Impact factor: 4.939

8.  Improved functional recovery of the isolated rat heart after 24 hours of hypothermic arrest with a stable prostacyclin analogue (ZK 36 374).

Authors:  W H van Gilst; P W Boonstra; J A Terpstra; C R Wildevuur; C D de Langen
Journal:  J Mol Cell Cardiol       Date:  1983-11       Impact factor: 5.000

9.  Studies of renal preservation using a rat kidney transplant model. Evaluation of citrate flushing.

Authors:  B Howden; D Rae; P Jablonski; V C Marshall; J Tange
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939

10.  Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury.

Authors:  O Sikujara; M Monden; K Toyoshima; J Okamura; G Kosaki
Journal:  Transplantation       Date:  1983-09       Impact factor: 4.939

View more
  1 in total

1.  The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.

Authors:  T Takahashi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.